Kathleen A. Rickard - 01 Nov 2022 Form 4 Insider Report for Verona Pharma plc (VRNA)

Signature
/s/ Claire Poll, Attorney-in-fact for Kathleen A. Rickard
Issuer symbol
VRNA
Transactions as of
01 Nov 2022
Net transactions value
-$137,147
Form type
4
Filing time
03 Nov 2022, 16:05:43 UTC
Previous filing
28 Sep 2022
Next filing
03 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Tax liability $90,022 -56,264 -1.8% $1.60* 3,119,776 01 Nov 2022 Direct F1, F2, F3
transaction VRNA Ordinary Shares Sale $47,125 -28,752 -0.92% $1.64* 3,091,024 01 Nov 2022 Direct F1, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units.
F3 The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 31, 2022 divided by eight (8).
F4 The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction.
F5 The price reported represents a weighted average sale price of the ADSs divided by eight (8). These shares were sold in multiple transactions at prices ranging from $1.6013 to $1.6738, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 Consists of (i) 2,141,880 Ordinary Shares underlying RSUs (which are represented by 267,735 ADSs); and (ii) 949,144 Ordinary Shares underlying 118,643 ADSs.